Neuralink Blindsight implant gets FDA green light
Increasingly neural implants are helping people regain the ability to see, feel, move, and much more.
Key takeaways
- The company has a long way to go before those claims can be proven true or false, but the FDA designation is a boost for Blindsight’s progress to market.
- The Breakthrough Devices programme aims to give patients and healthcare providers timely access to medical devices by speeding up the development, assessment and review of devices for premarket approval.
- Two patients have been implanted with this device so far and the company has shared exciting progress on both of these individuals.
Cite or link to this article
Griffin, M. (2024) 'Neuralink Blindsight implant gets FDA green light', 311 Institute, 15 October. Available at: https://www.311institute.com/neuralink-blindsight-product-gets-fda-green-light/ (Accessed: 1 October 2026).
Neuralink owner Elon Musk says that a new BlindSight device that helps restore peoples sight - even for those who’ve been blind since birth or even those who have ‘lost both eyes and their optic nerve’ - just got a big boost after it received a Breakthrough Device Designation from the US Food and Drug Administration (FDA), which will help speed up its development.
Neuralink kept the details of the new device vague and said it could “bring back sight to those who have lost it” and Musk claimed it could enable “even those who have lost both eyes and their optic nerve to see.”
“Provided the visual cortex is intact, it will even enable those who have been blind from birth to see for the first time,” Musk said.
In an X post he said the vision from this device will initially be at “low resolution,” but then claimed it could eventually become better than natural vision and “enable you to see in infrared, ultraviolet or even radar wavelengths,” like some of the cyborg-like implants that I’ve talked about before.
The company has a long way to go before those claims can be proven true or false, but the FDA designation is a boost for Blindsight’s progress to market. The Breakthrough Devices programme aims to give patients and healthcare providers timely access to medical devices by speeding up the development, assessment and review of devices for premarket approval.
This marks another victory for Neuralink, which has been focused on a human trial for a brain-implant device that lets people interact with devices without needing to use of their limbs. Two patients have been implanted with this device so far and the company has shared exciting progress on both of these individuals.
Neuralink received FDA approval last year to run clinical trials on humans, in the form of an investigational device exemption. This allows devices to be used in a clinical study in order to collect “safety and effectiveness data.”
The company has trialled the technology with pigs and monkeys over the years, with one monkey making headlines when it was shown playing the classic video game Pong with its mind. But like many companies associated with Musk, Neuralink has been hit with controversy in the past. The company faced federal investigation in the US for potential animal welfare violations during its trials.
FAQ
Why does this matter?
Increasingly neural implants are helping people regain the ability to see, feel, move, and much more.

About the author
Matthew Griffin Founder, 311 Institute
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."
Read full bio
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.
An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.
As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.
Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.
What future do you need to see?
Choose one to get started on biotech and enhanced humans and the future of your organisation.
Sources and further reading
- X x.com
Source: first published by the 311 Institute on 15 October 2024. Cite as: Griffin, M. (2024). Neuralink Blindsight implant gets FDA green light. 311 Institute. https://www.311institute.com/neuralink-blindsight-product-gets-fda-green-light/
You are welcome to quote this article with credit and a link to the original.